Highlights the potential for fatal proarrhythmic effects of flecainide in patients with WPW syndrome and atrial fibrillation, even with structurally normal hearts.
No takes yet. Share an insight, caveat, or question.
Raises caution for flecainide in WPW with AF even with normal hearts; single case leaves causal risk open for confirmation.
Chun et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: